Prebiotic Effect on Metabolites in Crohn's Disease

The purpose of this study is to investigate the influence of the prebiotic oligofructose enriched inulin on the metabolite pattern in Crohn's disease patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Crohn Disease Digestive System Diseases Gastroenteritis Gastrointestinal Diseases Inflammatory Bowel Diseases Intestinal Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

KULeuven

Leuven, 3000, Belgium

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

crohn's disease

Exclusion criteria

severe crohn's disease (harvey bradshaw index >12)
pregnancy
history of colectomy
use of antibiotics 4-wks before start of the study
use of sulfapyridine
use of commercially available prebiotics and probiotics

Treatment and study plan

Oligofructose enriched inulin

Dietary Supplement

Maltodextrin

Dietary Supplement

Sponsors and collaborators

Lead sponsor

KU Leuven

Other

Registry information

Official study title

Metabolite Profiling of the Impact of Oligofructose Enriched Inulin in Crohn's Disease Patients

Important dates

Study start: 2008
Study completion: 2009
First posted: Dec 7, 2011
Registry last updated: Dec 12, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed